BACKGROUND: X-linked nephrogenic diabetes insipidus (NDI) is a rare genetic renal disease caused by pathogenic variants in the AVPR2 gene. Single nucleotide variants and small insertions/deletions in AVPR2 are reliably detected by routine clinical sequencing. Nevertheless, structural variants involving AVPR2 are challenging to identify accurately by conventional genetic testing. Here, we report a novel deletion of AVPR2 in a Czech family identified for the first time by targeted long-read sequencing (T-LRS). METHODS: A male proband with X-linked NDI underwent clinical sequencing of the AVPR2 gene that failed and thus indicated possible whole-gene deletion. Therefore, PCR mapping and subsequent targeted long-read sequencing (T-LRS) using a Pacific Biosciences sequencer were applied to search for the suspected deletion. To validate the deletion breakpoints and prove variant segregation in the family with X-linked NDI, Sanger sequencing of the deletion junction was performed. Quantitative real-time PCR was further carried out to confirm the carrier status of heterozygous females. RESULTS: By T-LRS, a novel 7.5 kb deletion of AVPR2 causing X-linked NDI in the proband was precisely identified. Sanger sequencing of the deletion junction confirmed the variant breakpoints and detected the deletion in the probands´ mother, maternal aunt, and maternal cousin with X-linked NDI. The carrier status in heterozygous females was further validated by quantitative real-time PCR. CONCLUSIONS: Identifying the 7.5 kb deletion gave a precise molecular diagnosis for the proband, enabled genetic counselling and genetic testing for the family, and further expanded the spectrum of structural variants causing X-linked NDI. Our results also show that T-LRS has significant potential for accurately identifying putative structural variants.

Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Medical Genetics Faculty of Medicine in Pilsen Charles University and University Hospital Pilsen Pilsen Czech Republic

Department of Microbiology Faculty of Medicine in Pilsen Charles University and University Hospital Pilsen Pilsen Czech Republic

Department of Pediatrics Faculty of Medicine in Pilsen Charles University and University Hospital Pilsen Pilsen Czech Republic

Zobrazit více v PubMed

Knoers N, Lemmink H. Hereditary nephrogenic diabetes insipidus. Seattle (WA): University of Washington, Seattle; 1993. PubMed

Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015;11:576–588. doi: 10.1038/nrneph.2015.89. PubMed DOI

van den Ouweland AMW, Dreesen JCFM, Verdijk M, Knoers NVAM, Monnens LAH, Rocchi M, et al. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet. 1992;2:99–102. doi: 10.1038/ng1092-99. PubMed DOI

Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008;217:605–617. doi: 10.1002/jcp.21552. PubMed DOI

Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet. 1994;55:278–286. PubMed PMC

Anesi L, de Gemmis P, Galla D, Hladnik U. Two new large deletions of the AVPR2 gene causing nephrogenic diabetes insipidus and a review of previously published deletions. Nephrol Dial Transplant. 2012;27:3705–3712. doi: 10.1093/ndt/gfs359. PubMed DOI

Mitsuhashi S, Matsumoto N. Long-read sequencing for rare human genetic diseases. J Hum Genet. 2020;65:11–19. doi: 10.1038/s10038-019-0671-8. PubMed DOI

Leung MT, Sit JKK, Cheung HN, Iu YP, Chan WKY, Shek CC. Contiguous gene deletion in a Chinese family with X-linked nephrogenic diabetes insipidus: challenges in early diagnosis and implications for affected families. J Pediatr Endocrinol Metab. 2019;32:915–920. doi: 10.1515/jpem-2019-0028. PubMed DOI

Bai Y, Chen Y, Kong X. Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree. BMC Nephrol. 2018;19:26. doi: 10.1186/s12882-018-0825-5. PubMed DOI PMC

Huang L, Poke G, Gecz J, Gibson K. A novel contiguous gene deletion of AVPR2 and ARHGAP4 genes in male dizygotic twins with nephrogenic diabetes insipidus and intellectual disability. Am J Med Genet Part A. 2012;158A:2511–2518. doi: 10.1002/ajmg.a.35591. PubMed DOI

Marwaha S, Knowles JW, Ashley EA. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 2022;14:23. doi: 10.1186/s13073-022-01026-w. PubMed DOI PMC

Merker JD, Wenger AM, Sneddon T, Grove M, Zappala Z, Fresard L, et al. Long-read genome sequencing identifies causal structural variation in a Mendelian disease. Genet Med. 2018;20:159–163. doi: 10.1038/gim.2017.86. PubMed DOI PMC

Mizuguchi T, Suzuki T, Abe C, Umemura A, Tokunaga K, Kawai Y, et al. A 12-kb structural variation in progressive myoclonic epilepsy was newly identified by long-read whole-genome sequencing. J Hum Genet. 2019;64:359–368. doi: 10.1038/s10038-019-0569-5. PubMed DOI

Reiner J, Pisani L, Qiao W, Singh R, Yang Y, Shi L, et al. Cytogenomic identification and long-read single molecule real-time (SMRT) sequencing of a Bardet–Biedl Syndrome 9 (BBS9) deletion. NPJ Genomic Med. 2018;3:3. doi: 10.1038/s41525-017-0042-3. PubMed DOI PMC

Mizuguchi T, Okamoto N, Yanagihara K, Miyatake S, Uchiyama Y, Tsuchida N, et al. Pathogenic 12-kb copy-neutral inversion in syndromic intellectual disability identified by high-fidelity long-read sequencing. Genomics. 2021;113:1044–1053. doi: 10.1016/j.ygeno.2020.10.038. PubMed DOI

Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser. 1999;41:95–98.

Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094–3100. doi: 10.1093/bioinformatics/bty191. PubMed DOI PMC

Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178–192. doi: 10.1093/bib/bbs017. PubMed DOI PMC

Harel T, Lupski JR. Genomic disorders 20 years on-mechanisms for clinical manifestations. Clin Genet. 2018;93:439–449. doi: 10.1111/cge.13146. PubMed DOI

Tegay DH, Lane AH, Roohi J, Hatchwell E. Contiguous gene deletion involvingL1CAM andAVPR2 causes X-linked hydrocephalus with nephrogenic diabetes insipidus. Am J Med Genet Part A. 2007;143A:594–598. doi: 10.1002/ajmg.a.31536. PubMed DOI

Carroll P, Al-Mojalli H, Al-Abbad A, Al-Hassoun I, Al-Hamed M, Al-Amr R, et al. Novel mutations underlying nephrogenic diabetes insipidus in Arab families. Genet Med. 2006;8:443–447. doi: 10.1097/01.gim.0000223554.46981.7a. PubMed DOI

Demura M, Takeda Y, Yoneda T, Furukawa K, Usukura M, Itoh Y, et al. Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Hum Mutat. 2002;19:23–29. doi: 10.1002/humu.10011. PubMed DOI

Dong Y, Sheng H, Chen X, Yin J, Su Q. Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus. BMC Genet. 2006;7:53. doi: 10.1186/1471-2156-7-53. PubMed DOI PMC

Fujimoto M, Imai K, Hirata K, Kashiwagi R, Morinishi Y, Kitazawa K, et al. Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes. BMC Med Genet. 2008;9:42. doi: 10.1186/1471-2350-9-42. PubMed DOI PMC

Knops NBB, Bos KK, Kerstjens M, van Dael K, Vos YJ. Nephrogenic diabetes insipidus in a patient with L1 syndrome: a new report of a contiguous gene deletion syndrome including L1CAM and AVPR2. Am J Med Genet Part A. 2008;146A:1853–1858. doi: 10.1002/ajmg.a.32386. PubMed DOI

Kotnik P, Battelino T, Debeljak M, Podkrajšek KT, Waldhauser F, Frøkiaer J, et al. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus. J Pediatr Endocrinol Metab. 2007;20 PubMed

Schöneberg T, Pasel K, von Baehr V, Schulz A, Volk H-D, Gudermann T, et al. Compound deletion of the rhoGAP C1 and V2 vasopressin receptor genes in a patient with nephrogenic diabetes insipidus. Hum Mutat. 1999;14:163–174. doi: 10.1002/(SICI)1098-1004(1999)14:2<163::AID-HUMU8>3.0.CO;2-B. PubMed DOI

Schulz A, Sangkuhl K, Lennert T, Wigger M, Price DA, Nuuja A, et al. Aminoglycoside pretreatment partially restores the function of truncated V 2 vasopressin receptors found in patients with nephrogenic diabetes insipidus. J Clin Endocrinol Metab. 2002;87:5247–5257. doi: 10.1210/jc.2002-020286. PubMed DOI

Cho SY, Law CY, Ng KL, Lam CW. Novel large deletion in AVPR2 gene causing copy number variation in a patient with X-linked nephrogenic diabetes insipidus. Clin Chim Acta. 2016;455:84–86. doi: 10.1016/j.cca.2016.01.032. PubMed DOI

Broides A, Ault BH, Arthus M-F, Bichet DG, Ellen CM. Severe combined immunodeficiency associated with nephrogenic diabetes insipidus and a deletion in the Xq28 region. Clin Immunol. 2006;120:147–155. doi: 10.1016/j.clim.2006.05.001. PubMed DOI